 Alcon will buy glaucoma drugs maker Aerie Pharmaceuticals in a 770 million deal that sent the biotech stock flying Tuesday. The post Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For 770 Million appeared first on Investors Business Daily. 